Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q3 2021 · 10-Q
Revenue$2.32M$2.32M−1.4% vs Q3 2020 Net Income-$137.47K-$137.47KN/M vs Q3 2020 EPS Diluted-$0.02-$0.02N/M vs Q3 2020 Operating Income-$132,225N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$123,137−73.4% Margins · derivedOperating margin-5.7%−0.2 pt vs Q3 2020
Net margin-5.9%−0.5 pt vs Q3 2020
ended Mar 31, 2021 · filed May 14, 2021 · 44 d after period end